marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q3
added 11-08-2024
ANI Pharmaceuticals Balance Sheet 2011-2024 | ANIP
Annual Balance Sheet ANI Pharmaceuticals
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
65.3 M | 238 M | 187 M | 178 M | 123 M | 140 M | 170 M | 93.3 M | -41.3 M | -58.3 M | -11.1 M | -26.9 M | -39.9 M |
Long Term Debt |
285 M | 286 M | 287 M | 172 M | 176 M | 67.3 M | 198 M | 121 M | 113 M | 111 M | - | - | 17.3 M |
Long Term Debt Current |
1.56 M | 850 K | 850 K | 13.2 M | 9.94 M | 3.26 M | 3.35 M | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | - | 182 M | 67.8 M | 198 M | 121 M | 113 M | 111 M | - | - | 17.3 M |
Total Current Liabilities |
145 M | 99.4 M | 87.5 M | 78.6 M | 61.7 M | 166 M | 39.2 M | 31.9 M | 11.8 M | 13.2 M | 3.54 M | 10.6 M | 7.23 M |
Total Liabilities |
447 M | 422 M | 413 M | 265 M | 244 M | 233 M | 237 M | 153 M | 125 M | 124 M | 3.54 M | 10.6 M | 24.6 M |
Deferred Revenue |
- | - | - | 80 K | 451 K | 711 K | - | - | - | - | 47 K | - | - |
Retained Earnings |
-80.1 M | -97.3 M | -47.8 M | -4.97 M | 17.6 M | 11.5 M | -4.01 M | -2.92 M | -4.35 M | -19.7 M | -48.5 M | -245 M | -217 M |
Total Assets |
904 M | 760 M | 772 M | 461 M | 457 M | 431 M | 412 M | 323 M | 285 M | 264 M | 44.5 M | 38.8 M | 62.4 M |
Cash and Cash Equivalents |
221 M | 48.2 M | 100 M | 7.86 M | 62.3 M | 43 M | 31.1 M | 27.4 M | 155 M | 169 M | 11.1 M | 11 K | 57.2 M |
Book Value |
458 M | 339 M | 359 M | 196 M | 213 M | 197 M | 175 M | 170 M | 160 M | 140 M | 41 M | 28.2 M | 37.8 M |
Total Shareholders Equity |
433 M | 314 M | 334 M | 196 M | 213 M | 197 M | 175 M | 170 M | 160 M | 140 M | 41 M | -42.7 M | 37.8 M |
All numbers in USD currency
Quarterly Balance Sheet ANI Pharmaceuticals
| 2024-Q3 | 2024-Q2 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long Term Debt |
313 M | 284 M | 285 M | 285 M | 285 M | 286 M | 286 M | 286 M | 286 M | 287 M | 186 M | 190 M | 169 M | 172 M | 172 M | 172 M | 172 M | 176 M | 176 M | 176 M | 176 M | 67.3 M | 67.3 M | 67.3 M | 67.3 M | 69.9 M | 69.9 M | 69.9 M | 69.9 M | - | 121 M | 121 M | 121 M | 113 M | 113 M | 113 M | 113 M | 107 M | 111 M | 111 M | 111 M | - | - | - | - | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Liabilities |
857 M | 440 M | 435 M | 425 M | 426 M | 422 M | 402 M | 414 M | 399 M | 413 M | 279 M | 288 M | 260 M | 265 M | 265 M | 265 M | 265 M | 244 M | 244 M | 244 M | 244 M | 233 M | 233 M | 233 M | 233 M | 237 M | 237 M | 237 M | 237 M | 153 M | 153 M | 153 M | 153 M | 125 M | 125 M | 125 M | 125 M | 120 M | 124 M | 124 M | 124 M | 3.54 M | - | - | 9.33 M | 10.6 M | 10.9 M | 16.4 M | 16.6 M | 24.6 M | 24.6 M | 24.6 M | 24.6 M |
Deferred Revenue |
5 M | - | - | - | - | - | - | - | 116 K | 87 K | 62 K | 62 K | 62 K | 80 K | 80 K | 80 K | 318 K | 451 K | 451 K | 558 K | 624 K | 711 K | 735 K | 711 K | 711 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Retained Earnings |
-89.6 M | -65 M | -80.9 M | -90.4 M | -96.3 M | -97.3 M | -92.6 M | -83.6 M | -68.3 M | -47.8 M | -23.4 M | -19 M | -4.89 M | -4.97 M | -4.97 M | -4.97 M | -4.97 M | 17.6 M | 17.6 M | 17.6 M | 17.6 M | 11.5 M | 11.5 M | 11.5 M | 11.5 M | -4.01 M | -4.01 M | -4.01 M | -4.01 M | -2.92 M | -2.92 M | -2.92 M | -2.92 M | -4.35 M | -4.35 M | -4.35 M | -4.35 M | -19.7 M | -19.7 M | -19.7 M | -19.7 M | -48.5 M | -48.5 M | -48.5 M | -48.5 M | -43.8 M | -43.8 M | -43.8 M | -245 M | -217 M | -217 M | -217 M | -217 M |
Total Assets |
1.29 B | 921 M | 890 M | 859 M | 765 M | 760 M | 739 M | 751 M | 745 M | 772 M | 470 M | 480 M | 464 M | 461 M | 461 M | 461 M | 461 M | 457 M | 457 M | 457 M | 457 M | 431 M | 431 M | 431 M | 431 M | 412 M | 412 M | 412 M | 412 M | 323 M | 323 M | 323 M | 323 M | 285 M | 285 M | 285 M | 285 M | 260 M | 264 M | 264 M | 264 M | 44.5 M | 44.5 M | 44.5 M | 44.5 M | 13.7 M | 13.7 M | 13.7 M | 38.8 M | 62.4 M | 62.4 M | 62.4 M | 62.4 M |
Cash and Cash Equivalents |
145 M | 240 M | 193 M | 162 M | 67.8 M | 48.2 M | 56.3 M | 63.4 M | 76.9 M | 100 M | 15.3 M | 24.3 M | 25.1 M | 7.86 M | 7.86 M | 7.86 M | 7.86 M | 62.3 M | 62.3 M | 62.3 M | 62.3 M | 43 M | 43 M | 43 M | 43 M | 31.1 M | 31.1 M | 31.1 M | 31.1 M | 27.4 M | 27.4 M | 27.4 M | 27.4 M | 155 M | 155 M | 155 M | 155 M | 169 M | 169 M | 169 M | 169 M | 11.1 M | 11.1 M | 11.1 M | 11.1 M | 11 K | 11 K | 11 K | 34.8 M | - | 57.2 M | 57.2 M | 57.2 M |
Book Value |
431 M | 481 M | 455 M | 434 M | 339 M | 339 M | 337 M | 337 M | 346 M | 359 M | 191 M | 192 M | 204 M | 196 M | 196 M | 196 M | 196 M | 213 M | 213 M | 213 M | 213 M | 197 M | 197 M | 197 M | 197 M | 175 M | 175 M | 175 M | 175 M | 170 M | 170 M | 170 M | 170 M | 160 M | 160 M | 160 M | 160 M | 140 M | 140 M | 140 M | 140 M | 41 M | 44.5 M | 44.5 M | 35.2 M | 3.15 M | 2.83 M | -2.63 M | 22.2 M | 37.8 M | 37.8 M | 37.8 M | 37.8 M |
Total Shareholders Equity |
406 M | 456 M | 430 M | 410 M | 315 M | 314 M | 312 M | 312 M | 321 M | 334 M | 191 M | 192 M | 204 M | 196 M | 196 M | 196 M | 196 M | 213 M | 213 M | 213 M | 213 M | 197 M | 197 M | 197 M | 197 M | 175 M | 175 M | 175 M | 175 M | 170 M | 170 M | 170 M | 170 M | 160 M | 160 M | 160 M | 160 M | 140 M | 140 M | 140 M | 140 M | 41 M | 41 M | 41 M | 41 M | -42.7 M | -42.7 M | -42.7 M | 28.2 M | -34.3 M | 37.8 M | 37.8 M | 37.8 M |
All numbers in USD currency